MedPath

Patient-Provider Tools to Improve the Transition to Adult Care in Sickle Cell Disease

Not Applicable
Completed
Conditions
Sickle Cell Disease
Interventions
Behavioral: Self-management intervention for Adolescents with SCD
Behavioral: Patient Portal Intervention for Adolescents with SCD
Registration Number
NCT02200510
Lead Sponsor
Children's Hospital Medical Center, Cincinnati
Brief Summary

The purpose of the study is to develop patient-provider clinical support tools to improve clinical practice, patient self-management, and disease outcomes in sickle cell disease during transition to adult care. The investigators hypothesize that these clinical support tools (patient tool, provider tool, and patient/parent web-based portal) will be feasible, user friendly, and beneficial. The investigators hypothesize that participants will demonstrate better disease self-efficacy at the end of the 6 week intervention and maintain these gains during the follow-up period (up to 1 year post-intervention).

Detailed Description

The purpose of the study is to develop patient-provider clinical support tools to improve clinical practice, patient self-management, and disease outcomes in sickle cell disease during transition to adult care.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
78
Inclusion Criteria
  • Have sickle cell disease (SCD)
  • Between the ages of 13 and 24
  • Receive care at Cincinnati Children's Hospital Medical Center, University Hospital, University of Cincinnati Med Peds Practice, a practice in the Ohio Valley SCD Network, or another local provider
  • Parent/caregiver of a patient with SCD age 13-24 years
Exclusion Criteria
  • Below age 13
  • Have significant health complication(s) that would interfere with completion of the intervention (by physician report)
  • Have significant cognitive or developmental disabilities (by parent or physician report) due to high demand on participants to understand questions
  • Are not a patient at Cincinnati Children's Hospital Medical Center, University Hospital, University of Cincinnati Med Peds Practice, a practice in the Ohio Valley SCD Network, or another local provider
  • Are not a parent/caregiver of a patient with SCD age 13-24 years

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Self-Management GroupSelf-management intervention for Adolescents with SCDSelf-management intervention for Adolescents with SCD - 6 week self-management group
Patient PortalPatient Portal Intervention for Adolescents with SCDPatient Portal Intervention for Adolescents with SCD - 6 week individual patient portal intervention
Primary Outcome Measures
NameTimeMethod
Change From Baseline on Disease Self-efficacy Measure at 6 Weeksbaseline, 6 weeks (post-intervention)

Name of Measure: Sickle Cell Self-Efficacy Scale (SCSES). Construct: sickle cell self-efficacy (disease specific self-efficacy) 9 item measure of sickle cell disease self-efficacy (likert scale from 1 \[not at all sure\] to 5 \[very sure\]) developed by Edwards (see References).

Responses on items are summed to compute a total score. Minimum score: 9 Maximum score: 45 Higher scores represent higher sickle cell self-efficacy (better outcome).

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Cincinnati Children's Hospital Medical Center

🇺🇸

Cincinnati, Ohio, United States

© Copyright 2025. All Rights Reserved by MedPath